Your browser doesn't support javascript.
loading
Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial.
Baraliakos, Xenofon; Pournara, Effie; Gossec, Laure; Mease, Philip J; White, Roisin; O'Brien, Eamonn; Schulz, Barbara; Marzo-Ortega, Helena; Coates, Laura C.
Afiliação
  • Baraliakos X; Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Bochum, Germany Xenofon.Baraliakos@elisabethgruppe.de.
  • Pournara E; Immunology, Hepatology and Dermatology, Novartis Pharma AG, Basel, Basel-Stadt, Switzerland.
  • Gossec L; Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Mease PJ; Rheumatology Department, Pitié-Salpêtrière Hospital, AP-HP.Sorbonne Université, Paris, France.
  • White R; Rheumatology Research, Swedish Medical Center, Providence St Joseph Health and University of Washington, Seattle, Washington, USA.
  • O'Brien E; Novartis Ireland Limited, Dublin, Ireland.
  • Schulz B; Novartis Ireland Limited, Dublin, Ireland.
  • Marzo-Ortega H; Immunology, Hepatology and Dermatology, Novartis Pharma AG, Basel, Basel-Stadt, Switzerland.
  • Coates LC; Section of Musculoskeletal Disease, NIHR Leeds Biomedical Research Centre, LTHT and LIRMM, University of Leeds, Leeds, UK.
RMD Open ; 8(2)2022 07.
Article em En | MEDLINE | ID: mdl-35850974

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article